• A High-Throughput Surrogate Model for BBB Permeability Predi

  2026-07-27

  Hu et al. present a robust in vitro model integrating LLC-PK1-MOCK/MDR1 cells and lysosomal trapping correction to predict blood-brain barrier (BBB) permeability with high accuracy. This innovation enables efficient early-stage CNS drug screening by reliably distinguishing passive diffusion, transporter-mediated efflux, and intracellular sequestration.

• Regulation of BIRC2/BIRC3 by Cytokines and Glucocorticoids i

  2026-07-26

  The referenced study uncovers distinct regulatory mechanisms of BIRC2 and BIRC3 expression in pulmonary epithelial cells in response to inflammatory cytokines and glucocorticoids. These findings refine the molecular understanding of apoptosis modulation and NF-κB signaling in airway biology, with implications for inflammatory lung disease models.

• Prestained Protein Marker: Triple Color Precision for SDS-PA

  2026-07-25

  The Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) streamlines protein size verification and transfer tracking across SDS-PAGE and Western blot workflows. Its triple-color, EDTA-free design uniquely supports advanced imaging and compatibility with phospho-proteomics assays, setting a new standard for reproducibility and visual clarity.

• Dutasteride: Dual 5-Alpha-Reductase Inhibitor in Prostate Re

  2026-07-24

  Dutasteride’s robust dual 5-alpha-reductase inhibition unlocks precise androgen modulation for advanced prostate cancer and BPH research. This guide offers detailed experimental workflows, troubleshooting strategies, and actionable protocol enhancements to improve data reliability and reproducibility.

• DAMGO: Precision µ-Opioid Receptor Agonist in Pain Research

  2026-07-24

  DAMGO stands out as a gold-standard µ-opioid receptor agonist for dissecting opioid receptor signaling, enabling researchers to model analgesia, tolerance, and hypersensitivity with unmatched selectivity. This article delivers actionable workflows, troubleshooting strategies, and a translation of recent circuit-level findings into experimental design guidance.

• PYR-41, Inhibitor of Ubiquitin-Activating Enzyme E1: Applied

  2026-07-23

  PYR-41, a selective inhibitor of Ubiquitin-Activating Enzyme E1, is transforming research into the ubiquitin-proteasome system and NF-κB signaling. This article provides detailed experimental protocols, troubleshooting strategies, and contextualizes recent breakthroughs, making PYR-41 indispensable for dissecting protein degradation and immune signaling in cancer and inflammation models.

• Optimizing Necroptosis Assays with CA-074 Me Cathepsin B Inh

  2026-07-23

  Leverage CA-074 Me for precise dissection of lysosomal pathways in cell death, as validated by breakthrough studies in necroptosis and inflammation models. Discover protocol upgrades, troubleshooting tactics, and comparative insights for robust, reproducible results in apoptosis and TNF-α-induced liver injury research.

• Prednisone in Immunology: Applied Workflows and Troubleshoot

  2026-07-22

  Prednisone, a synthetic corticosteroid from APExBIO, delivers precise immunosuppression and apoptosis control, enabling robust models for immunology and neurodegeneration research. This guide bridges recent metabolomic insights, hands-on protocol enhancements, and troubleshooting strategies to empower reproducible, data-driven experimentation.

• EZ Cap™ EPO mRNA: Advancing Neurorepair and Erythropoiesis R

  2026-07-22

  EZ Cap™ EPO mRNA (ψUTP) enables robust, immune-silent erythropoietin expression for both erythropoiesis and neuroprotection studies. Its advanced Cap 1 structure and pseudouridine modification set new standards for mRNA stability and translational efficiency in disease modeling and therapeutic research.

• n-Dodecyl-β-D-maltoside: Optimizing Membrane Protein Purific

  2026-07-21

  n-Dodecyl-β-D-maltoside (DDM) enables high-yield solubilization and stabilization of challenging membrane proteins—crucial for cutting-edge cryo-EM workflows and protein–lipid interaction studies. Learn how to unlock reproducible, structurally intact samples and troubleshoot common pitfalls, with actionable protocol parameters and insights from the latest integrin structural biology breakthroughs.

• Protein Corona Effects on Nanoparticle Delivery and Expressi

  2026-07-21

  Elizabeth Voke’s dissertation delivers a robust proteomics workflow to characterize how protein corona formation on nanoparticles—especially lipid nanoparticles—alters their biological fate and gene delivery efficiency. The work highlights the disconnect between nanoparticle uptake and mRNA expression, providing mechanistic insights critical for optimizing both agricultural nanosensors and clinical mRNA therapeutics.

• Autophagy-Induced Lipid Breakdown in Salmon: Insights for Li

  2026-07-20

  Phadwal et al. establish that autophagy regulates lipid breakdown and mitigates lipotoxicity in Atlantic salmon cells, using global lipidomics and proteomics to map these pathways. Their findings advance the understanding of lipid metabolism in aquaculture species and provide a robust model for studying autophagy's role in non-mammalian systems.

• Methyl-β-cyclodextrin: Practical Protocols for Membrane Stud

  2026-07-20

  Methyl-β-cyclodextrin is used to selectively extract cholesterol and specific lipids from cellular membranes, enabling research into membrane fluidity modulation and lipid raft dynamics. It is not intended for diagnostic or therapeutic use and requires careful handling to maintain reagent integrity.

• AMPK–SQSTM1 Feedback Enhances Antioxidant Defense in Metabol

  2026-07-19

  This study uncovers a double-positive feedback loop between AMPK and SQSTM1/p62, leading to the simultaneous activation of AMPK and NFE2L2/NRF2 under metabolic stress. The findings clarify mechanisms of antioxidant adaptation in cancer, with implications for disease modeling and targeted intervention.

• MRTFA-KCNMB1 Axis Regulates Cancer Cell Stiffness and Metast

  2026-07-18

  Gajda et al. uncover how the MRTFA-KCNMB1 axis modulates cancer cell stiffness through potassium channel regulation, influencing metastatic colonization and immune evasion. Their work reveals that pharmacological activation of BK channels can stiffen cancer cells, enhancing susceptibility to lymphocyte-mediated destruction and suggesting a novel biomechanical strategy for limiting metastasis.

421 records 8/29 page Previous Next First page 上5页 678910 下5页 Last page